$XBI updated daily chart haven't posed since the 21st. moved up stops and likely will put some shares into let it ride today.
Source: Sunrise Trader
Write something you'd like to share with our community...
The Nasdaq Biotechnology Index fell 3% in a single session. Fulcrum Therapeutics dropped 51%. Abivax ADR declined 44%. To someone unfamiliar with biotech investing, these numbers look like a sector-wi...
$XBI updated daily chart haven't posed since the 21st. moved up stops and likely will put some shares into let it ride today.
Source: Sunrise Trader

$XBI took my paydays shares off for good payday %. I now settle into the full swing with $ in my pocket Wash, rinse and repeat the same system over and over again.
Source: Sunrise Trader
Took some profit out of $ROBN and $XBI still own shares in both.
Source: Sunrise Trader
• Market rally hesitates due to escalating tensions in the Strait of Hormuz.
• $Palantir Tech(PLTR.US)'s Q1 earnings and revenue exceeded estimates, driven by growth in its U.S. government business. • $XBI shows strength. • Lattice Semiconductor $Lattice Semicon(LSCC.US) and $ON Semiconductor(ON.US) Semiconductor both reported strong earnings, but ON's stock dropped. • $Grayscale Bitcoin Mini Trust ETF(BTC.US) approaches $80,000 following a compromise on the Clarity Act regarding stablecoin yields. • $Eli Lilly(LLY.US) recovered after a patient experienced liver failure from its weight-loss pill. • $Mirum Pharmaceuticals(MIRM.US) shares surged to an all-time high due to positive liver disease treatment results.Moving some stops to no green to red $XBI $CrowdStrike(CRWD.US)
Source: Sunrise Trader
$XBI daily pullback to 50ma and bounce. A move and hold over the 10/21ma's if price wants it are next on my radar.
Source: Sunrise Trader

$XBI my paydays sold for OK payday %. Still a day trade for now. I have swing plan ready.
Source: Sunrise Trader
Don't sleep on Biotech 🧪 $XBI
Source: TrendSpider

Good


The biotech sector is really like a roller coaster ride, with XBI seeing large capital outflows and LABU leveraged ETFs plummeting... Despite all analysts saying this sector is worth watching in 2026, why is the short-term performance so disappointing? After tasting the bitterness of volatility, I finally understand making money isn't that easy. But perhaps with more patience, we might still see a turnaround. Everyone, hold tight and keep watching.
Under the pressure of interest rate cuts, small-cap stocks like $SPDR S&P Biotech(XBI.US) are rising much faster than large-cap stocks like $Alphabet(GOOGL.US)😂

The impact of interest rate cuts on small and mid-cap biotech stocks in the US market is immediate$Direxion S&P Biotech Bull 3X(LABU.US)$SPDR S&P Biotech(XBI.US)

Adjusting the portfolio again, cutting $AMD(AMD.US) in half. Chasing some $SPDR S&P Biotech(XBI.US)$Direxion S&P Biotech Bull 3X(LABU.US), waiting for the market to continue trading on rate cut and recession expectations.

There's already a crazy trend for 15/21 years. The funds from high-position profit-taking are sitting idle, afraid of missing out, and need to find 1-2 relatively low positions for defensive counterattacks. $PDD(PDD.US) $Meituan(MPNGY.US)$SPDR S&P Biotech(XBI.US) I think they are all good.